Handene L, Janssen F et al. CD81 gene defect in humans disrupts CD19 complex formation and results in antibody deficiency. J Clin Invest 2010; 120: 1265274. 6 Fliegauf M, Bryant VL, Frede N, Slade C, Woon S-T, Lehnert K et al. Haploinsufficiency with the NF-B1 subunit p50 in prevalent variable immunodeficiency. Am J Hum Genet 2015; 97: 38903. 7 Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency illnesses: an update around the classification in the international union of immunological societies expert committee for primary immunodeficiency 2015. J Clin Immunol. 2015; 35: 69626. eight Ameratunga R, Woon ST, Neas K, Adore DR. The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case primarily based overview. Allergy Asthma Clin Immunol 2010; six: 12. 9 Ameratunga R, Woon ST, Brewerton M, Koopmans W, Jordan A, Brothers S et al. Key immune deficiency disorders within the South Pacific: the clinical utility of a customized genetic testing system in New Zealand. Ann NY Acad Sci 2011; 1238: 534. 10 Pan-Hammarstrom Q, Salzer U, Du L, Bjorkander J, Cunningham-Rundles C, Nelson DL et al. Reexamining the role of TACI coding variants in frequent variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; 39: 42930.4,6-Dichloro-5-nitropicolinic acid web 11 Poodt AE, Driessen GJ, de Klein A, van Dongen JJ, van der Burg M, de Vries E. TACI mutations and disease susceptibility in individuals with frequent variable immunodeficiency. Clin Exp Immunol 2009; 156: 359. 12 Koopmans W, Woon ST, Brooks AE, Dunbar PR, Browett P, Ameratunga R. Clinical variability of household members with all the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). J Clin Immunol 2013; 33: 683. 13 Bateson. Discussion around the influence of heredity on illness, with unique reference to tuberculosis, cancer, and diseases in the nervous technique: introductory address. Proc R Soc Med 1909; two(Gen Rep): 220. 14 Hill WG, Goddard ME, Visscher PM. Data and theory point to mainly additive genetic variance for complicated traits. PLoS Genet 2008; 4: e1000008. 15 Mackay TF, Moore JH. Why epistasis is very important for tackling complex human illness genetics.2-Chloro-4,6-dimethoxyaniline uses Genome Med 2014; six: 124.PMID:25804060 16 Schaffer AA. Digenic inheritance in healthcare genetics. J Med Genet 2013; 50: 64152. 17 Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R et al. Comparison of diagnostic criteria for Frequent Variable Immunodeficiency Disorder. Front Immunol 2014; 5: 415. 18 Ameratunga R, Storey P, Barker R, Jordan A, Koopmans W, Woon ST. Application of diagnostic and therapy criteria for frequent variable immunodeficiency disorder. Expert Rev Clin Immunol 2015; 12: 25766. 19 Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for CVID. Professional Rev Clin Immunol 2014; ten: 18386. 20 Agarwal S, Cunningham-Rundles C. Remedy of hypogammaglobulinemia in adults: a scoring method to guide choices on immunoglobulin replacement. J Allergy Clin Immunol 2013; 131: 1699701. 21 Denis CM, Langelaan DN, Kirlin AC, Chitayat S, Munro K, Spencer HL et al. Functional redundancy amongst the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300. Nucleic Acids Res 2014; 42: 7370382. 22 Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC et al. E2A proteins are expected for right B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994; 79: 88592. 23 Quong MW, Harri.
